Ida Minchella

1.6k total citations
44 papers, 1.2k citations indexed

About

Ida Minchella is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ida Minchella has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 18 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ida Minchella's work include Cancer Treatment and Pharmacology (14 papers), Breast Cancer Treatment Studies (13 papers) and HER2/EGFR in Cancer Research (10 papers). Ida Minchella is often cited by papers focused on Cancer Treatment and Pharmacology (14 papers), Breast Cancer Treatment Studies (13 papers) and HER2/EGFR in Cancer Research (10 papers). Ida Minchella collaborates with scholars based in Italy, United Kingdom and Switzerland. Ida Minchella's co-authors include Giuseppe Curigliano, Aron Goldhirsch, Franco Nolè, Angela Espósito, Carmen Criscitiello, Marzia Locatelli, Laura Adamoli, Elisabetta Munzone, Lucia Gelao and Luca Fumagalli and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.

In The Last Decade

Ida Minchella

43 papers receiving 1.2k citations

Peers

Countries citing papers authored by Ida Minchella

Since Specialization

Citations

This map shows the geographic impact of Ida Minchella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ida Minchella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ida Minchella more than expected).

Fields of papers citing papers by Ida Minchella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ida Minchella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ida Minchella. The network helps show where Ida Minchella may publish in the future.

Co-authorship network of co-authors of Ida Minchella

This figure shows the co-authorship network connecting the top 25 collaborators of Ida Minchella. A scholar is included among the top collaborators of Ida Minchella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ida Minchella. Ida Minchella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tearing down inequalities in the healthcare system across Europe: the BEACON project 2025 ·Frontiers in Public Health ·(unknown), (unknown), (unknown), (unknown), (unknown), Dario Trapani, Ida Minchella, Roberto Grasso, Giuseppe Curigliano, Gabriella Pravettoni	0
2	Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials 2021 ·Cancers ·Pamela Trillo Aliaga, Dario Trapani, José Luís Sandoval, Edoardo Crimini, Gabriele Antonarelli, (unknown), Stefania Morganti, Chiara Corti, Paolo Tarantino, Alex Friedlaender, Carmen Belli, Ida Minchella, Marzia Locatelli, Angela Espósito, Carmen Criscitiello, Giuseppe Curigliano	10
3	Predictive role of derived neutrophil to lymphocyte ratio on platinum-based chemotherapy in triple-negative breast cancer 2019 ·Annals of Oncology ·Antonio Marra, Giuseppe Viale, Dario Trapani, Eleonora Nicolò, Stefania Morganti, Alessandro Esposito, Ida Minchella, Carmen Criscitiello, Giuseppe Curigliano, Marco Locatelli	1
4	Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer 2018 ·Expert Opinion on Pharmacotherapy ·Bruno A. Duso, Dario Trapani, Giulia Viale, Carmen Criscitiello, Paolo D’Amico, Carmen Belli, Luca Mazzarella, Marzia Locatelli, Ida Minchella, Giuseppe Curigliano	4
5	ecancermedicalscience 2016 ·ecancermedicalscience ·Lucia Gelao, Carmen Criscitiello, Luca Fumagalli, (unknown), (unknown), Anna Esposito, Ida Minchella, Aron Goldhirsch, Giuseppe Curigliano	17
6	Mechanisms of anorexia–cachexia syndrome and rational for treatment with selective ghrelin receptor agonist 2015 ·Cancer Treatment Reviews ·Angela Espósito, Carmen Criscitiello, Lucia Gelao, Gabriella Pravettoni, Marzia Locatelli, Ida Minchella, (unknown), (unknown), Alessandra Milani, (unknown), Giuseppe Curigliano	26
7	QTc prolongation induced by targeted biotherapies used in clinical practice and under investigation: a comprehensive review 2014 ·Targeted Oncology ·Marzia Locatelli, Carmen Criscitiello, Angela Espósito, Ida Minchella, Aron Goldhirsch, Carlo M. Cipolla, Giuseppe Curigliano	14
8	High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in Luminal B HER2 negative and node-positive breast cancer 2013 ·The Breast ·Carmen Criscitiello, Davide Disalvatore, Michelino De Laurentiis, Lucia Gelao, Luca Fumagalli, Marzia Locatelli, Vincenzo Bagnardi, Nicole Rotmensz, Angela Espósito, Ida Minchella, Sabino De Placido, Michele Santangelo, Giuseppe Viale, Aron Goldhirsch, Giuseppe Curigliano	84
9	Best management of locally advanced inoperable breast cancer 2013 ·European Journal of Cancer Supplements ·Giuseppe Curigliano, Carmen Criscitiello, Angela Espósito, Luca Fumagalli, Lucia Gelao, Marzia Locatelli, Ida Minchella, Aron Goldhirsch	5
10	Preoperative therapy with trastuzumab and oral vinorelbine (± endocrine therapy) in patients with HER2-positive breast cancer 2010 ·The Breast ·Monica Iorfida, Vincenzo Bagnardi, Alessandra Balduzzi, Silvia Dellapasqua, Anna Cardillo, Alberto Luini, Mattia Intra, Ida Minchella, Paolo Veronesi, Giuseppe Viale, Aron Goldhirsch, Marco Colleoni	5
11	Changes of HER2 Status in Circulating Tumor Cells Compared With the Primary Tumor During Treatment for Advanced Breast Cancer 2010 ·Clinical Breast Cancer ·Elisabetta Munzone, Franco Nolè, Aron Goldhirsch, Edoardo Botteri, Angela Espósito, Laura Zorzino, Giuseppe Curigliano, Ida Minchella, Laura Adamoli, Maria Cristina Cassatella, Chiara Casadio, Maria Teresa Sandri	77
12	Metronomic administration of pegylated liposomal-doxorubicin in extensively pre-treated metastatic breast cancer patients: A mono-institutional case-series report 2009 ·The Breast ·Elisabetta Munzone, Attilio Di Pietro, Aron Goldhirsch, Ida Minchella, Elena Verri, Maria Cossu Rocca, C. Marenghi, Giuseppe Curigliano, Davide Radice, Laura Adamoli, Franco Nolè	23
13	Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer 2008 ·Cancer Chemotherapy and Pharmacology ·K. Lorizzo, Nicola Fazio, Davide Radice, S. Boselli, (unknown), Maria Giulia Zampino, Franco Nolè, Elena Magni, Raffaele Ardito, Ida Minchella, Andrea Rocca, Giovanni Di Meglio, (unknown), Filippo de Braud	11
14	Optimizing clinical care of patients with metastatic breast cancer: a new oral vinorelbine plus trastuzumab combination 2007 ·Annals of Oncology ·Chiara Catania, M. Médici, Elisabetta Magni, Elisabetta Munzone, Daniela Cardinale, Laura Adamoli, Giuseppina Sanna, Ida Minchella, Davide Radice, Aron Goldhirsch, Franco Nolè	11
15	Capecitabine/Vinorelbine: An Effective and Well-Tolerated Regimen for Women with Pretreated Advanced-Stage Breast Cancer 2006 ·Clinical Breast Cancer ·Franco Nolè, Chiara Catania, Elisabetta Munzone, Andrea Rocca, Elena Verri, Giuseppina Sanna, Tiziana Ascione, Laura Adamoli, M.G. Zampino, Ida Minchella, Aron Goldhirsch	25
16	Mediastinal lymphoadenopathy in a patient with breast cancer 2002 ·The Lancet Oncology ·Giuseppe Curigliano, Mario Mandalà, Ida Minchella, Aron Goldhirsch	2
17	Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: A phase II study 2001 ·Annals of Oncology ·Franco Nolè, Elisabetta Munzone, Mario Mandalà, Chiara Catania, Laura Orlando, Maria Giulia Zampino, Ida Minchella, Marco Colleoni, G. Peruzzotti, (unknown), Aron Goldhirsch	22
18	Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors 2000 ·Annals of Oncology ·Marco Colleoni, Ida Minchella, Giovanni Mazzarol, Franco Nolè, G. Peruzzotti, Andrea Rocca, Giuseppe Viale, Laura Orlando, G. Ferretti, Giuseppe Curigliano, Paolo Veronesi, Mattia Intra, Aron Goldhirsch	81
19	Pre-operative chemotherapy and radiotherapy in breast cancer 1998 ·European Journal of Cancer ·Marco Colleoni, F. Nolè, Ida Minchella, Cristina Noberasco, Alberto Luini, (unknown), Paolo Veronesi, Stefano Zurrida, Giuseppe Viale, Aron Goldhirsch	24
20	Phase I–II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: A regimen with a low subjective toxic burden 1997 ·Annals of Oncology ·Franco Nolè, Filippo de Braud, Matti Aapro, Ida Minchella, (unknown), Maria Giulia Zampino, Simonetta Monti, Giuseppe Andreoni, Aron Goldhirsch	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact